Abstract:The oral and lung microbiomes connection through the oral–lung axis leads to an oral and lung health and disease intimate and bi‐directional relationship. In this mini‐review, we discuss opportunities for the airway microbiome to make a positive impact on the clinical management of respiratory health, aimed at personalization and assisted by multi‐omics data integration and computational modelling. The human respiratory system is constantly exposed to environmental stimuli, sometimes including toxicants, which can trigger dysregulated lung immune responses that lead to respiratory symptoms, impaired lung function and airway diseases. Evidence supports that the microbiome in the lungs has an indispensable role in respiratory health and disease, acting as a local gatekeeper that mediates the interaction between the environmental cues and respiratory health. Moreover, the microbiome in the lungs is intimately intertwined with the oral microbiome through the oral–lung axis. Here, we discuss the intricate three‐way relationship between (i) cigarette smoking, which has strong effects on the microbial community structure of the lung; (ii) microbiome dysbiosis and disease in the oral cavity; and (iii) microbiome dysbiosis in the lung and its causal role in patients suffering chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality worldwide. We highlight exciting outcomes arising from recently established interactions in the airway between environmental exposures, microbiome, metabolites–functional attributes and the host, as well as how these associations have the potential to predict the respiratory health status of the host through an airway microbiome health index. For completion, we argue that incorporating (synthetic) microbial community ecology in our contemporary understanding of lung disease presents challenges and also rises novel opportunities to exploit the oral–lung axis and its microbiome towards innovative airway disease diagnostics, prognostics, patient stratification and microbiota‐targeted clinical interventions in the context of current therapies.

The upper airway microbiota: how host and environment shape this ecological niche

The microbiome of the upper respiratory tract in health and disease

Host and environmental factors shape upper airway microbiota and respiratory health across the human lifespan

Host–microorganism interactions in lung diseases

Lung Microbiota and Its Impact on the Mucosal Immune Phenotype

Microbiome and disease in the upper airway

Environmental exposures, the oral–lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function

The Human Respiratory Microbiome: Current Understandings and Future Directions

Genomic attributes of airway commensal bacteria and mucosa

The Lower Airway Microbiome in Paediatric Health and Chronic Disease

Upper Respiratory Dysbiosis with a Facultative-Dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.

Role of the gut microbiota in airway immunity and host defense against respiratory infections

Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia

Exploring the lung microbiome's role in disease

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

The role of oral microbiome in respiratory health and diseases

The dynamic lung microbiome in health and disease

Niche exclusion of a lung pathogen in mice with designed probiotic communities

Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections

The gut–airway microbiome axis in health and respiratory diseases

The Lung Microbiome